{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:00:44Z","timestamp":1792728044327,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s13346-021-00978-7","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T12:04:44Z","timestamp":1618488284000},"page":"1096-1104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["\u03b3-Cyclodextrin metal\u2013organic framework as a carrier to deliver triptolide for the treatment of hepatocellular carcinoma"],"prefix":"10.1007","volume":"12","author":[{"given":"Zhe","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunai","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med"},{"key":"978_CR2","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.7150\/thno.34713","volume":"9","author":"H Chen","year":"2019","unstructured":"Chen H, Wong CC, Liu D, Go M, Wu B, Peng S, et al. APLN promotes hepatocellular carcinoma through activating PI3K\/Akt pathway and is a druggable target. Theranostics. 2019;9:5246\u201360.","journal-title":"Theranostics"},{"issue":"216\u2013217","key":"978_CR3","first-page":"220","volume":"63","author":"N Fares","year":"2013","unstructured":"Fares N, Peron JM. Epidemiology, natural history, and risk factors of hepatocellular carcinoma. Rev Prat. 2013;63(216\u2013217):220\u20132.","journal-title":"Rev Prat"},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.7150\/thno.35378","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang X, Liu T, Li Z, Feng Y, Corpe C, Liu S, et al. Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH(-)). Theranostics. 2019;9:8109\u201326.","journal-title":"Theranostics"},{"key":"978_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.surg.2014.04.055","volume":"156","author":"OA Alsaied","year":"2014","unstructured":"Alsaied OA, Sangwan V, Banerjee S, Krosch TC, Chugh R, Saluja A, et al. Sorafenib and triptolide as combination therapy for hepatocellular carcinoma. Surgery. 2014;156:270\u20139.","journal-title":"Surgery"},{"key":"978_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbrc.2018.01.052","volume":"496","author":"X Li","year":"2018","unstructured":"Li X, Lu Q, Xie W, Wang Y, Wang G. Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt\/beta-Catenin signaling. Biochem Biophys Res Commun. 2018;496:443\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2217\/pgs.13.122","volume":"14","author":"F Chen","year":"2013","unstructured":"Chen F, Liu Y, Wang S, Guo X, Shi P, Wang W, et al. Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1alpha and Nrf2. Pharmacogenomics. 2013;14:1305\u201317.","journal-title":"Pharmacogenomics"},{"key":"978_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/10717544.2018.1425777","volume":"25","author":"C Lin","year":"2018","unstructured":"Lin C, Zhang X, Chen H, Bian Z, Zhang G, Riaz MK, et al. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide. Drug Deliv. 2018;25:256\u201366.","journal-title":"Drug Deliv"},{"key":"978_CR9","first-page":"830","volume":"16","author":"H Liu","year":"2018","unstructured":"Liu H, Tang L, Li X, Li H. Triptolide inhibits vascular endothelial growth factor-mediated angiogenesis in human breast cancer cells. Exp Ther Med. 2018;16:830\u20136.","journal-title":"Exp Ther Med"},{"key":"978_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13046-018-0698-2","volume":"37","author":"SG Li","year":"2018","unstructured":"Li SG, Shi QW, Yuan LY, Qin LP, Wang Y, Miao YQ, et al. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2018;37:51.","journal-title":"J Exp Clin Cancer Res"},{"key":"978_CR11","doi-asserted-by":"publisher","first-page":"8027","DOI":"10.1021\/nn502074x","volume":"8","author":"D Ling","year":"2014","unstructured":"Ling D, Xia H, Park W, Hackett MJ, Song C, Na K, et al. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma. ACS Nano. 2014;8:8027\u201339.","journal-title":"ACS Nano"},{"key":"978_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.inoche.2018.07.029","volume":"96","author":"L Zhang","year":"2018","unstructured":"Zhang L, Chen Y, Shi R, Rang T, Pang G, Wang B, et al. Synthesis of hollow nanocages MOF-5 as drug delivery vehicle to solve the load-bearing problem of insoluble antitumor drug oleanolic acid (OA). Inorg Chem Commun. 2018;96:20\u20133.","journal-title":"Inorg Chem Commun"},{"key":"978_CR13","doi-asserted-by":"publisher","first-page":"105377","DOI":"10.1016\/j.phrs.2020.105377","volume":"165","author":"Q Ren","year":"2021","unstructured":"Ren Q, Li M, Deng Y, Lu A, Lu J. Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity. Pharmacol Res. 2021;165:105377. https:\/\/doi.org\/10.1016\/j.phrs.2020.105377.","journal-title":"Pharmacol Res"},{"key":"978_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.carbpol.2019.04.037","volume":"216","author":"I Kritskiy","year":"2019","unstructured":"Kritskiy I, Volkova T, Surov A, Terekhova I. gamma-Cyclodextrin-metal organic frameworks as efficient microcontainers for encapsulation of leflunomide and acceleration of its transformation into teriflunomide. Carbohydr Polym. 2019;216:224\u201330.","journal-title":"Carbohydr Polym"},{"key":"978_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.foodchem.2016.06.013","volume":"212","author":"Z Moussa","year":"2016","unstructured":"Moussa Z, Hmadeh M, Abiad MG, Dib OH, Patra D. Encapsulation of curcumin in cyclodextrin-metal organic frameworks: Dissociation of loaded CD-MOFs enhances stability of curcumin. Food Chem. 2016;212:485\u201394.","journal-title":"Food Chem"},{"key":"978_CR16","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1021\/acs.molpharmaceut.7b00168","volume":"14","author":"KJ Hartlieb","year":"2017","unstructured":"Hartlieb KJ, Ferris DP, Holcroft JM, Kandela I, Stern CL, Nassar MS, et al. Encapsulation of Ibuprofen in CD-MOF and Related Bioavailability Studies. Mol Pharm. 2017;14:1831\u20139.","journal-title":"Mol Pharm"},{"key":"978_CR17","doi-asserted-by":"publisher","first-page":"115935","DOI":"10.1016\/j.carbpol.2020.115935","volume":"235","author":"Y He","year":"2020","unstructured":"He Y, Hou X, Guo J, He Z, Guo T, Liu Y, et al. Activation of a gamma-cyclodextrin-based metal-organic framework using supercritical carbon dioxide for high-efficient delivery of honokiol. Carbohydr Polym. 2020;235:115935.","journal-title":"Carbohydr Polym"},{"key":"978_CR18","doi-asserted-by":"crossref","unstructured":"Chen G, Luo J, Cai M, Qin L, Wang Y, Gao L, et al. Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier. Molecules. 2019; 24.","DOI":"10.3390\/molecules24183369"},{"key":"978_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2016.06.003","volume":"235","author":"Y Bao","year":"2016","unstructured":"Bao Y, Yin M, Hu X, Zhuang X, Sun Y, Guo Y, et al. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. J Control Release. 2016;235:182\u201394.","journal-title":"J Control Release"},{"key":"978_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijpharm.2018.11.024","volume":"554","author":"Y Gu","year":"2019","unstructured":"Gu Y, Tang X, Yang M, Yang D, Liu J. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis. Int J Pharm. 2019;554:235\u201344.","journal-title":"Int J Pharm"},{"key":"978_CR21","doi-asserted-by":"crossref","unstructured":"Duran-Lobato M, Martin-Banderas L, Goncalves LMD, Fernandez-Arevalo M, Almeida AJ. Comparative study of chitosan- and PEG-coated lipid and PLGA nanoparticles as oral delivery systems for cannabinoids. J Nanopart Res. 2015; 17.","DOI":"10.1007\/s11051-015-2875-y"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00978-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-021-00978-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00978-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T14:00:26Z","timestamp":1648044026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-021-00978-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s13346-021-00978-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-97854\/v1","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"5 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiment was approved by the Ethics Committee of Ninth People\u2019s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine before the research (approval number SH9H-2020-A144-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}